Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China
· Delayed Price · Currency is CNY 14.75
+0.23 (1.58%)
Mar 10, 2026, 9:34 AM CST
SHE:002755 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 13,477 | 11,797 | 10,043 | 7,370 | 11,815 | 12,122 | Upgrade
|
| Market Cap Growth | 7.64% | 17.47% | 36.27% | -37.63% | -2.53% | -19.18% | Upgrade
|
| Enterprise Value | 11,121 | 9,955 | 8,433 | 5,757 | 10,477 | 10,821 | Upgrade
|
| Last Close Price | 14.52 | 12.63 | 10.75 | 7.89 | 12.52 | 12.65 | Upgrade
|
| PE Ratio | 54.34 | 73.60 | - | - | 31.10 | 16.80 | Upgrade
|
| Forward PE | - | 15.30 | 15.30 | 15.30 | 15.30 | 15.41 | Upgrade
|
| PS Ratio | 7.38 | 6.64 | 6.96 | 3.94 | 3.80 | 3.21 | Upgrade
|
| PB Ratio | 4.12 | 3.75 | 3.34 | 2.45 | 3.66 | 4.00 | Upgrade
|
| P/TBV Ratio | 5.07 | 4.05 | 3.59 | 2.57 | 3.79 | 4.12 | Upgrade
|
| P/FCF Ratio | 51.58 | 65.20 | - | - | 27.23 | 31.84 | Upgrade
|
| P/OCF Ratio | 23.83 | 28.68 | - | - | 20.81 | 20.89 | Upgrade
|
| EV/Sales Ratio | 6.09 | 5.60 | 5.84 | 3.08 | 3.37 | 2.86 | Upgrade
|
| EV/EBITDA Ratio | 40.12 | 58.61 | - | - | 26.11 | 13.11 | Upgrade
|
| EV/EBIT Ratio | 54.63 | 105.29 | - | - | 33.83 | 14.77 | Upgrade
|
| EV/FCF Ratio | 42.56 | 55.02 | - | - | 24.14 | 28.42 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.04 | 0.02 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.19 | 0.42 | - | - | 0.03 | 0.02 | Upgrade
|
| Debt / FCF Ratio | 0.20 | 0.40 | - | - | 0.03 | 0.05 | Upgrade
|
| Net Debt / Equity Ratio | -0.74 | -0.64 | -0.54 | -0.52 | -0.52 | -0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | -8.84 | -11.90 | 7.84 | 6.94 | -4.17 | -1.76 | Upgrade
|
| Net Debt / FCF Ratio | -9.27 | -11.17 | 10.50 | 7.65 | -3.86 | -3.81 | Upgrade
|
| Asset Turnover | 0.44 | 0.47 | 0.42 | 0.53 | 0.83 | 1.01 | Upgrade
|
| Inventory Turnover | 2.37 | 1.83 | 1.80 | 1.73 | 1.78 | 1.58 | Upgrade
|
| Quick Ratio | 2.56 | 2.85 | 4.62 | 6.05 | 5.69 | 3.57 | Upgrade
|
| Current Ratio | 2.72 | 3.13 | 5.07 | 6.60 | 6.19 | 3.84 | Upgrade
|
| Return on Equity (ROE) | 7.08% | 4.18% | -6.89% | -8.53% | 12.16% | 26.14% | Upgrade
|
| Return on Assets (ROA) | 3.03% | 1.56% | -5.23% | -5.48% | 5.14% | 12.21% | Upgrade
|
| Return on Invested Capital (ROIC) | 21.95% | 6.43% | -20.51% | -20.79% | 18.50% | 45.67% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 2.90% | -9.40% | -10.10% | 9.30% | 23.50% | Upgrade
|
| Earnings Yield | 1.90% | 1.36% | -1.48% | -3.06% | 3.21% | 5.95% | Upgrade
|
| FCF Yield | 1.94% | 1.53% | -1.55% | -2.76% | 3.67% | 3.14% | Upgrade
|
| Dividend Yield | 0.82% | 0.95% | - | - | 0.80% | 1.58% | Upgrade
|
| Payout Ratio | 43.62% | 0.72% | - | - | 48.89% | 28.43% | Upgrade
|
| Buyback Yield / Dilution | -4.80% | -1.57% | 1.34% | -1.55% | -0.16% | 0.49% | Upgrade
|
| Total Shareholder Return | -3.98% | -0.62% | 1.34% | -1.55% | 0.64% | 2.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.